πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7166619

Prenylation inhibitors and methods of their synthesis and use

PPD Discovery, Inc. Β· Granted Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7161003

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

Pharmacopeia Drug Discovery, Inc. Β· Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7157495

Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benz

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7157476

Aminofurazan compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7151101

Inhibitors of p38

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7132392

Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7132420

Aspartic protease inhibitors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7125845

Aza-peptide macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7122552

Inhibitors of JAK and CDK2 protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7119200

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

Pharmacopeia Drug Discovery, Inc. Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7119105

Methods for treating neurodegenerative disorders using aspartyl protease inhibitors

The Regents of the University of California Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7115637

Inhibitors of p38

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7115739

Triazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7109172

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7098216

Thiazolopyrimidines useful as TNFΞ± inhibitors

The Regents of the University of California Β· Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7098330

Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7091343

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 15 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7087603

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7087642

Inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7084159

Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7084271

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

Pharmacopeia Drug Discovery, Inc. Β· Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7078508

Ixodes scapularis tissue factor pathway inhibitor

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7078525

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

Pharmacopeia Drug Discovery, Inc. Β· Granted Tue Jul 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7078209

CAK inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted